Delivery Order SPE2DB25D3402-SPE2DB25FUGDE

Award Date 5/1/25
Potential Completion Date 5/22/25
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BENLYSTA 200 MG/ML AUTOINJECTORML, a pharmaceutical product, with a ceiling value of $9,975.58 and a performance period ending on May 19, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of Benlysta, a 200 mg/ml autoinjector medication, with a ceiling value of $2,793.03 and a performance period through May 3, 2024. The contract is a firm fixed price arrangement with no set-aside designation. In addition to this delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BENLYSTA 200 MG/ML AUTOINJECTML, a pharmaceutical product. The contract is not set aside and has a ceiling value of $19,951.16. It is a firm fixed-price delivery order contract with a period of performance through May 12, 2025. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BENLYSTA 200 MG/ML AUTOINJECTOR, a specialty medication, with a ceiling value of $5,586.06 and a period of performance through November 12, 2024. The contract is a firm-fixed-price delivery order, and there is no set-aside designation, indicating open competition. AmerisourceBergen also holds a $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BENLYSTA 200 MG/ML AUTOINJECTOR, a medication, with a ceiling value of $4,987.78 and a period of performance through May 6, 2025. The contract is a firm fixed-price delivery order, which indicates a pre-determined unit price for the ordered items. This contract is not designated as a set-aside, meaning it was open to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of BENLYSTA 200 mg/mL autoinjectors. The contract has a ceiling value of $11,172.12 and an ultimate completion date of August 28, 2024. The contract is a firm-fixed-price delivery order, which is a commonly used contract type for the supply of pharmaceutical products to federal agencies. This award is likely part of a larger Indefinite Delivery Contract (IDC)...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BENLYSTA 200 MG/ML AUTOINJECTOR, a specialty medication, with a ceiling value of $3,082.67 and a completion date of January 27, 2025. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. AmerisourceBergen also holds a $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BENLYSTA 200 MG/ML AUTOINJECTML, a pharmaceutical product, with a ceiling value of $6,165.34 and a completion date of April 22, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Benlysta 200 mg/mL autoinjector. The single-award contract has a firm fixed price of $10,805.40 and an ultimate completion date of September 7, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,975.58, is for the delivery of BENLYSTA 200 MG/ML autoinjectors. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as a primary...
  • SPE2DB25D3402
    Indefinite Delivery Contract
  • SPE2DB25D3402-SPE2DB25FUGDE
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Benlysta 200 mg/ml autoinjectors. The contract has a ceiling value of $9,975.58 and a performance period extending through May 2025. It is a firm fixed-price contract, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is part of the company's broader role as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 7/31/25, 10:17 AM